SCHEMBL3565416

SCHEMBL3565416

CN(C)c1ccc(Nc2ccc3c(c2)/C(=C/Nc2ccc(CN4CCCCC4)cc2)C(=O)NC3=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
ROCK2 O75116 1/20 0.37
CDK4 P11802 1/20 0.37
CCND1 P24385 1/20 0.37
KDM4E B2RXH2 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
GFER P55789 1/20 0.36
PAK1 Q13153 1/20 0.36
LMNA P02545 1/20 0.35
SYK P43405 2/20 0.35
JAK2 O60674 1/20 0.35
TERT O14746 2/20 0.35
CASP3 P42574 1/20 0.34
CASP2 P42575 1/20 0.34
CASP7 P55210 1/20 0.34
CASP6 P55212 1/20 0.34
CASP8 Q14790 1/20 0.34
CCR2 P41597 1/20 0.34
EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3565419 1.00 ALDH1A1 (0.47) ALDH1A1ROCK2CDK4CCND1KDM4E
SCHEMBL3574577 0.90 APP (0.40) ALDH1A1CDK4CCND1KDM4EKMT2A
SCHEMBL3574573 0.90 APP (0.40) ALDH1A1CDK4CCND1KDM4EKMT2A
SCHEMBL3567788 0.89 CDK4 (0.46) ALDH1A1CDK4CCND1KDM4EKMT2A
SCHEMBL3571191 0.89 KDM4E (0.43) ALDH1A1CDK4CCND1KDM4EPAK1
SCHEMBL3567794 0.89 CDK4 (0.46) ALDH1A1CDK4CCND1KDM4EKMT2A
SCHEMBL3571195 0.89 KDM4E (0.43) ALDH1A1CDK4CCND1KDM4EPAK1
SCHEMBL3567526 0.87 KMT2A (0.46) ALDH1A1CDK4CCND1KDM4EKMT2A
SCHEMBL3567529 0.87 KMT2A (0.46) ALDH1A1CDK4CCND1KDM4EKMT2A
SCHEMBL3565548 0.86 HRH3 (0.43) ALDH1A1ROCK2CDK4CCND1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US claimed
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 ALDH1A1 61/4885ROCK2 1815/4885CDK4 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.